Functional Inhibitory Control Dynamics in Impulse Control Disorders in Parkinson’s Disease by Paz-Alonso, Pedro M. et al.
1	
	
Functional inhibitory control dynamics in impulse control disorders in 
Parkinson’s disease 
Paz-Alonso PM, PhD,1* Navalpotro-Gomez I, MD,2,3,4* Boddy P, MSc,1 Dacosta R, 
PhD,2,3 Delgado-Alvarado M, MD, PhD,2,3,5,6,7 Quiroga-Varela A, PhD,2,3,8,Jimenez-
Urbieta H, MSc,2,3 Carreiras M, PhD,1,9 and Rodriguez-Oroz MC, MD,PhD,1,3,8,9,10 
1BCBL. Basque Center on Cognition, Brain and Language, Donostia-San Sebastián, 
Spain  
2Neurodegenerative Disorders Area, Biodonostia Health Research Institute, Donostia-
San Sebastián, Spain 
3CIBERNED. Network Center for Biomedical Research in Neurodegenerative Diseases, 
Madrid, Spain 
4Servei de Neurologia, Hospital del Mar, Parc de Salut Mar-IMIM, Barcelona, Spain 
5Neurology Department, Sierrallana Hospital, Torrelavega, Spain 
6IDIVAL, Valdecilla Biomedical Research Institute, Santander, Spain 
7Biomedical Research Networking Center for Mental Health (CIBERSAM), Madrid 
Spain 
8Neuroscience Area, Center for Applied Medical Research (CIMA), Universidad de 
Navarra, Pamplona, Spain 
9Ikerbasque (Basque Foundation for Science), Bilbao, Spain 
10Department of Neurology, Clínica Universidad de Navarra, Universidad de Navarra, 
Pamplona, Spain 
*P.M.P-A and I.N-G contributed equally to this work as joint first authors. 
Corresponding authors: Maria C Rodriguez-Oroz, Department of Neurology, Clinica 
Universidad de Navarra, Universidad de Navarra, Pamplona, Spain. Phone: 
+34948255400 Ext: 4511; E-mail address: mcroroz@unav.es. Pedro M. Paz-Alonso, 
2	
	
BCBL, Basque Center on Cognition, Brain and Language, Donostia-San Sebastián, 
Spain. Phone: +34943300309; E-mail address: ppazalonso@bcbl.eu.	
Key words: Parkinson´s disease, impulse control disorders, reward processing, 






• Background: Impulse control disorders (ICD) related to alterations in the 
mesocorticolimbic dopamine network occur in Parkinson’s disease (PD). Our objective 
is to investigate the functional neural substrates of reward processing and inhibitory 
control in these patients.  
• Methods: Eighteen PD patients with ICD, 17 without this complication, and 18 
healthy controls, performed a version of the Iowa Gambling Task during functional 
magnetic resonance scanning under three conditions: positive, negative and mixed 
feedback. Whole-brain contrasts, regions-of-interest, time courses, functional 
connectivity analyses and brain-behavior associations were examined. 
• Results: PD patients with ICD exhibited hyperactivation in subcortical and 
cortical regions typically associated with reward processing and inhibitory control 
compared to their PD and healthy control counterparts. Time course analyses revealed 
that only PD patients with ICD exhibited stronger signal intensity during the initial 
versus final periods of the negative feedback condition in bilateral insula, and right 
ventral striatum. Interestingly, hyperactivation of all the examined right-lateralized 
fronto-striatal areas during negative feedback was positively associated with ICD 
severity. Importantly, positive associations between ICD severity and regional 
activations in right insula and right inferior frontal gyrus, but not right subthalamic 
nucleus, were mediated by functional connectivity with right ventral striatum. 
• Conclusions: During a reward-based task, PD patients with ICD showed 
hyperactivation in a right-lateralized network of regions, including the subthalamic 
nucleus that was strongly associated with ICD severity. In these patients, the right 
ventral striatum in particular, play a critical role in modulating the functional dynamics 




Impulse control disorders (ICD), including pathological gambling, binge eating, 
compulsive shopping, hypersexuality and other impulsive-compulsive behaviors (ICBs) 
are reported to occur at least in 13.6% of patients with Parkinson disease (PD) on 
dopaminergic medication1,2. Importantly, ICD can result in devastating financial, legal, 
or psychosocial problems3.  
Although the neuropathophysiological basis of ICD in PD patients is not well 
understood, it has been hypothesized to occur as a result of chronic administration of 
dopaminergic drugs, which modulate the reward network in PD patients4. Confirming 
the role of dopamine as a reinforcement signal shaping future motivated behaviors, 
positron emission tomography studies focused on the dopaminergic system indicate that 
ICDs in PD are associated with a higher release of dopamine in the ventral striatum 
(VS) during reward-related tasks5,6. However, functional magnetic resonance imaging 
(fMRI) studies using reward-related tasks in PD patients with ICD (PD-ICD) show 
discrepant results: while two studies pointed towards diminished activation in right VS, 
orbitofrontal (OFC) and anterior cingulate cortices (ACC)7,8, three other studies showed 
higher activation in VS, anterior prefrontal cortex (PFC), ACC, and OFC9–11. These 
discrepancies could be due to methodological factors, such as clinical differences in the 
PD populations studied (e.g., PD severity, ICD subtype, with or without treatment), the 
use of different reward-related tasks (e.g., related or not to a specific ICD subtype), 
MRI imaging protocols and analytical approaches. Moreover, while few studies have 
investigated functional connectivity (FC) during incentive-based tasks in PD-ICD 
patients12,13, the limited evidence available indicates mesolimbic pathway alterations 
and suggests ICD in PD patients reflect disruptions beyond this pathway.  
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In addition, studies of PD-ICD patients highlight a critical imbalance between learning 
from rewards and penalties14, suggesting that chronic dopaminergic treatment might 
cause tonic stimulation of dopamine receptors, desensitizing the dopaminergic reward 
system by preventing the decreases in dopaminergic transmission that normally occur 
with penalties15. Furthermore, previous evidence has revealed that, in PD patients with 
or without ICD, dopaminergic drugs respectively decrease or increase activity in brain 
areas implicated in inhibitory control16, classically strongly lateralized to the right 
hemisphere17. In this sense, the Iowa Gambling Task (IGT) is a useful experimental 
paradigm extensively used in clinical research to examine reward-related and inhibitory 
control processes in a decision-making context simulating real-life situations that has 
not been previously used with fMRI to examine the functional dynamics of reward and 
inhibitory control processes in PD-ICD. 
Previous fMRI studies with normal adults using the IGT provide evidence that areas 
related to reward processing and inhibitory control such as the middle frontal gyrus 
(MFG), insula, OFC, ventromedial PFC, VS, ACC and supplementary motor area 
(SMA) are involved in the execution of this task18,19. On the other hand, clinical studies 
evaluating the performance of the IGT have reported that PD patients may show higher 
losses20 or, conversely, intact or even more cautious performance of the task21,22, 
reflecting opposite motivational expressions along a continuous behavioral spectrum 
involving hypo- and hyper-dopaminergic symptoms23. Neuroanatomical correlates of 
studies using the IGT task with PD patients point towards an association with the 
volumetry of limbic cortical areas24,25 or with the function of the limbic fronto-striatal 
circuit of the basal-ganglia26. Interestingly, behavioral studies that have assessed the 
IGT task in PD-ICD patients have also shown mixed findings27,28, further underscoring 
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the need to investigate the neural dynamics of PD-ICD patients during reward-related 
and inhibitory control processes in a decision-making task such as the IGT. 
Our aim is to investigate the neural mechanisms underlying decision-making and 
inhibitory control processes in PD-ICD patients while performing the IGT task using 
fMRI. Specifically, in this study we sought to examine whether the type of feedback 
and ICD severity affects regional activation and FC between regions along the 
mesocorticolimbic circuit in PD-ICD patients. We hypothesized that these patients, 
would exhibit differential functional activation and connectivity patterns involving 
regions belonging to the mesocorticolimbic circuit, specifically the VS, during their 
execution of decision making and inhibitory control processes required by the IGT. 
2. MATERIAL AND METHODS. 
2.1. Participants 
The final study sample included 53 participants comprised of three groups: 18 PD-ICD 
patients, 17 PD patients without ICD symptoms (PD-noICD), and 18 healthy controls 
(HC). Participants in each group were matched on age, sex, education and premorbid 
Intelligence Quotient. All PD patients were diagnosed according to the UK Parkinson’s 
Disease Society Brain Bank criteria and recruited from the Movement Disorders Unit of 
the Hospital Donostia (Spain). Inclusion criteria for the PD-ICD group included at least 
one current ICD that had emerged after PD diagnosis and the initiation of dopamine 
replacement therapy. Each patient was routinely asked about any abnormal behavior 
and both a neurologist and a psychiatrist assessed and confirmed the presence of ICD 
based on the Diagnostic and Statistical Manual of Mental Disorders research criteria 
and on the Questionnaire for Impulsive-Compulsive Disorders in PD29. ICD symptom 
severity was then evaluated via the Questionnaire for Impulsive-Compulsive Disorders 
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in Parkinson’s Disease-Rating Scale (QUIP-RS)30. In addition, we also confirmed that 
every PD-ICD patient had a QUIP-RS score above the published cut-off for each ICD 
subtype. Exclusion criteria were dementia31 or mild cognitive impairment according to 
the Movement Disorders Society Task Force criteria (Level II)32, dyskinesias, brain 
surgery; and those ICD patients who were no longer symptomatic when examined were 
also excluded. HC were recruited from the Basque Center on Cognition, Brain and 
Language (BCBL) pool of participants. This study was approved by the Gipuzkoa 
Clinical Research Ethics Committee and written informed consent was obtained from 
all the subjects. 
2.2. Demographic and clinical assessment 
All assessments were performed using a comprehensive battery of motor, behavior and 
cognitive tests as described in Table 1 (Demographic and clinical characteristics) and in 
Supplementary Table 1 (Neuropsychological test scores). Details of each patient’s ICD 
characteristics are provided in Supplementary Table 2. Decision-making was assessed 
using the computerized version of the classical IGT, in which patients have to choose 
between four decks of cards in an attempt to win as much money as possible, across five 
blocks of task trials33. They have to take into account that some decks (advantageous) 
will tend to reward the player more often that other decks (disadvantageous; see 
Supplementary Data for a full description of the classical IGT). Afterwards, this 
classical IGT was compared with participants’ in-scanner performance on the modified 
version of the IGT used in the present fMRI study. Details on the statistical analyses 
conducted on the demographic and clinical data are described in Supplementary Data. 
All assessments as well as MRI scanning of PD patients was done in the morning while 
they were still under the effect of their first regular dose of dopaminergic medication. 
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Table 1. Demographic and clinical characteristics of the sample. 





Post-hoc (Bonferroni or U-
Mann Whitney) 




Sex, male (%) 16 (88.9%) 15 (88.2%) 15 (83.3%) 0.866
b
  
Education (years) 14.5 [9.8-18.5] 12 [10-17] 15 [9.5-20] 0.570
c
  
Premorbid IQ (WAIS-III 
Vocabulary) 46 [38.8-51.8] 49 [39-3.5] 50 [44.8-57.3] 0.193
c
  
Disease duration (years) 8 [5.1-10] 7 [4-10] - 0.960
e
  














 940.6 (94.9) 841.4 (62.4) - 0.455d  
HADS total 8.1 (7.3) 6.3 (2.8) 5.2 (3.2) 0.092a 
 




HADS-depression 3.1 (2.4) 2.2(2.6) 1.9 (1.3)  0.145a  
QUIP-RS score 17  (7.5)              0.4 (0.7) - <0.0001d  
TCI-R Novelty Seeking total 100.5 (14.6) 84.8 (9.8) 84.4 (20.9) 0.005a PD-ICD>PD-noICD (p=0.016) 
PD-ICD>HC (p=0.011) 
NS1 Exploratory excitability 29.9 (7.2) 26.5 (3.8) 25.3 (5.3) 0.045a PD-ICD>HC (p=0.049) 





NS3 Extravagance 27.1 (4.3) 23.9 (3.5) 24.1 (5) 0.058
a
  
NS4 Disorderliness 17.8 (6.1) 14.5 (4) 15.3 (2.8) 0.248
a
  
Barratt Impulsiveness total 48.3 (11.7) 30.9 (8.4) 25.4 (8.2) <0.001a PD-ICD>PD-noICD (p=0.004) PD-ICD>HC (p=0.003) 










Barratt Non-planning 16.1 (9) 9.9 (3.2) 8 (4.8) 0.001
a
 PD-ICD>PD-noICD (p=0.016) 
Starkstein score 6.6 (2.3) 3.5 (2.9) 1.9 (1.2) 0.013a PD-ICD>HC (p=0.01)  
Iowa Gambling Task 
outside scanner (CD minus 
AB, %) 
39.2 (12.4) 41.3 (23.4) 43.7 (27.7) 0.113f  
 
Modified Iowa Gambling-
Task in-scanner (No-risk 
minus risk, % ) 
26.8 (18.1) 35.4 (12.5) 38.9 (29.9) 0.548f  
      
Values expressed in mean (SD) for parametric variables, in median and IQ range in non-
parametric variables 
 a One factorANOVA; b Chi-Square; c Kruskall-Wallis; d Two-sample T-test; e U Mann Whitney; 
f Repeated measures ANOVA 
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Abbreviations: IQ = Intelligence Quotient; WAIS-III = Wechsler Adult Intelligence Scale-III; 
UPDRS = Unified Parkinson’s Disease Rating Scale; H&Y=Hoehn and Yahr scale; LEDDDA: 
levodopa equivalent daily dose of dopamine agonist was calculated using the formula described 
by Tomlinson et al. (Tomlinson et al., 2010); LEDDTOTAL= Total levodopa equivalent daily dose 
was calculated according to the same formula; HADS=Hospital Anxiety and Depression Scale; 
QUIP-RS= Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating 
Scale; TCI-R=Revised Temperament and Character Inventory; NS=Novelty Seeking Subscales. 
 
2.3. MRI data acquisition 
Functional and structural images were obtained at the BCBL using a 3T Siemens 
Magnetom TIM Trio MRI scanner using a 32-channel head coil. See Supplemental data 
for further information on MRI data acquisition.  
2.4. Functional magnetic resonance imaging paradigm  
At the scanner participants performed a modified version of the IGT task. Before 
starting the IGT, participants were instructed that their aim was to gain as much money 
as possible. However, they were not informed about the IGT contingencies and had to 
learn them from feedback on their card choices, that is, their monetary gains and losses. 
The fMRI design conformed to a slow event-related design with gambling-related visual 
cues alternating with neutral stimuli.  
 We used a simplified version of the IGT to minimize motor difficulties 
experienced by PD patients during scanning and to assure that they could understand the 
IGT contingencies. Instead of the original version (with decks A, B, C and D), we used 
a version with only two decks (A and B). One of the decks was disadvantageous, 
providing larger gains but larger losses resulting in a net loss over time. The other deck 
was advantageous, providing smaller gains but smaller losses resulting in a net gain 
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over time. These deck contingencies were kept consistent across conditions (i.e., 
positive, negative and mixed), regardless of the feedback specifically provided in each 
of these conditions. The subject chose a card from either of the two decks, then a 
message was displayed on the screen indicating the amount of money the subject had 
won or lost. The task was divided into 3 conditions always presented in the same 
sequential order: (1) only positive feedback was presented, so the participants could get 
familiarized with the decks providing lower and higher gains (positive); (2) negative 
feedback was presented, so participants could get familiarized with the decks providing 
higher and lower losses (negative); and, (3) positive and negative rewards were 
provided, so participants could either win or lose money based on the contingencies 
learned in sections 1 and 2 (see Supplementary Data for a further description of the 
modified IGT used here). Participants performed this modified version of the IGT 
across three functional runs. Within each of these functional runs, participants 
performed two blocks, each including the three sequential sections (6 in total). Blocks 
presented within the same functional run differed from each other in regard to 
advantageous and disadvantageous rules applied, and participants were instructed to 
ignore previous contingencies when moving from one block to the next one. Between 
blocks participants performed a control task where they encountered two decks (A and 
B) with different amounts written on each deck and they just needed to choose the deck 
with the highest number. 
2.5. MRI data analyses 
To examine potential group differences in gray-matter surface we used participants’ T1-
weighted images to run Freesurfer’s mri_glmfit. This analysis revealed no significant 
differences for any of the possible group comparisons. 
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Further details on the MRI data preprocessing and analyses are reported in 
Supplementary Data. In brief, SPM8 was used to conduct standard preprocessing 
routines and analyses. Statistical analyses were performed on individual participants’ 
data using the general linear model (GLM). The fMRI time series data were modeled by 
a series of events convolved with a canonical hemodynamic response function. Four 
fMRI task experimental conditions were analyzed separately as epochs from the onset 
of the presentation of the first stimulus within each section (positive feedback, negative 
feedback, mixed feedback) and control task. The resulting functions were used as 
covariates in a GLM, along with the motion parameters for translation and rotation as 
covariates of non-interest. The model was created to examine the neural changes 
restricted to the three task sections and the control task periods and was used in whole-
brain contrast, regions-of-interest (ROIs), time course and FC analyses. Additionally, 
brain-behavior associations with ICD severity in PD-ICD patients were examined for 
ROI and FC analyses. Finally, mediation analyses were conducted to examine whether 
in PD-ICD patients FC mediates the relation between ICD severity and regional 
activation (see Supplementary Data for details).  
3. RESULTS 
3.1.Demographic and clinical data 
No differences were seen in demographic data, dopaminergic medication or clinical 
features with the exception of impulsivity scores that were significantly higher in PD-
ICD patients than in PD-noICD patients and HC (Table 1 and Supplementary Table 1). 
There were 6 patients who reported a single ‘isolated’ ICD and 12 patients with 
‘combined’ ICD/ICB (Supplementary Table 2). 
	
3.2. In- and out-scanner IGT results  
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The ANOVA on the net scores of the classical IGT that participants performed outside 
of the scanner revealed no significant main effects of Group (F(2, 50)=2.28; p=0.11, 
ηp2=0.08) and Condition (F(2, 50)=1.61; p=0.18, ηp2=0.08), nor Group by Condition 
interaction (F(2, 50) =1.51; p=0.20, ηp2=0.05). The results on the modified in-scanner 
IGT task resembled the results obtained with the classical IGT (Supplementary Fig.1). 
We also compared classical IGT task results with modified in-scanner IGT task results 
revealing no differences between both task performance (F(2, 50)=1.02; p=0.366, 
ηp2=0.04). 
3.3.MRI results 
3.3.1. Whole-brain analysis 
To identify brain regions involved in the in-scanner functional IGT task across all 
participants, we computed a whole-brain contrast for all the activation conditions versus 
the control condition (All Conditions > Control). This contrast revealed activation in 
fronto-parietal networks, including bilateral inferior and superior parietal cortex and 
bilateral inferior, middle and superior PFC18. Also, significant engagement of bilateral 
insula, OFC, VS and right STN were shown in this contrast.  
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Figure 1 Brain rendering and axial sections showing ROI analyses that revealed main 
group effects in % signal change. In red are shown regions with stronger activation for 
the PD-ICD group compared to the HC group. Regions in green showed higher 
activation for the PD-ICD group compared to the PD-noICD group. MFG = Middle 
frontal gyrus; OFC = orbitofrontal cortex; SMA = supplementary motor area; IFG = 
inferior frontal gyrus; STN = subthalamic nucleus; VS = ventral striatum. 
 
3.3.2. ROI analysis 
ROI analysis showed stronger regional activation in PD-ICD patients compared with 
HC across the 3 conditions of the IGT in the following regions (areas in red in Fig.1): 
left MFG (F(2, 49)=5.84; p=0.005, ηp2=0.19), left medial OFC (F(2, 50) =3.81; p=0.03, 
ηp2=0.13), right MFG (F(2, 49)=2.69; p=0.03, ηp2=0.14) and right SMA (F(2, 50) =4.43; 
p=0.017, ηp2=0.15). Group effects in these regions were not observed for PD-ICD versus 
PD-noICD. 
ROI analysis also showed hyperactivation in PD-ICD patients compared to PD-noICD 
patients across the 3 conditions of the IGT in the following regions (areas in green in 
Fig.1): right STN (F(2, 49)=3.36; p=0.04, ηp2=0.12), right IFG (F(2, 50)=3.38; p=0.04, 
ηp2=0.12), and right VS (F(2, 50)=3.58; p=0.03, ηp2=0.13). Moreover, PD-noICD patients 
showed hypoactivation compared to HC only in bilateral dorsal striatum (Fs(2, 
50)=3.19; ps≤0.04, ηp2≥0.12). 
3.3.3. Time-course analysis 
The ANOVA conducted on the BOLD signal intensity extracted from time-course 
analyses in each ROI revealed a Group X Condition X Time interaction in the left insula 
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(F(2,50)=1.7; p=0.01, ηp2=0.264), right insula (F(2, 50)=1.72; p=0.01, ηp2=0.25) and right 
VS (F(2, 50)=1.48; p=0.04, ηp2=0.16). Post-hoc analyses in all three regions revealed 
that only PD-ICD patients exhibited significantly higher signal intensity during the 
negative feedback condition in the initial bin of the period (0-8 secs) compared to the 
second bin of the period (8-16 secs) in the left insula (F(2, 18)=6.7; p=0.003, ηp2=0.45), 
right insula (F(2, 18)=7.2; p=0.002, ηp2=0.30) and right VS (F(2, 18)=5.3; p=0.01, 
ηp2=0.24) (Fig.2). These effects were not observed in PD-noICD patients, or in HC 
(ps≥0.09).
 
Figure 2 Time-course analysis of ROIs (in axial sections) showing a Group X 
Condition X Time interaction: bilateral insula and right VS. All these regions 
demonstrated larger BOLD signal intensity in the negative feedback condition for the 
PD-ICD group during the initial period relative to the PD-noICD and HC groups. This 




3.3.4. QUIP correlates, functional connectivity, and mediation analysis 
In PD-ICD patients, positive associations were found between regional activation 
during negative feedback and QUIP-RS scores for some of the right-lateralized ROIs: 
STN (r(16)=0.75; q=0.001), MFG (r(16)=0.50; q=0.02), IFG (r(16)=0.53; q=0.02), 
SMA (r(16)=0.50; q=0.02), insula (r(16)=0.52; q=0.02) and VS (r(16)=0.62; q=0.01).  
To examine if the association between regional activation during the negative feedback 
condition and ICD severity was mediated by specific patterns of FC among these areas, 
we first examined whether pairwise FC among the above mentioned six right-lateralized 
ROIs was associated with ICD severity (Fig.3A). FC during the negative feedback 
condition among 4 of these six areas (i.e., STN, VS, IFG and insula) was associated 
with ICD severity: VS-STN (r(16)=0.77; q=0.001), VS-insula (r(16)=0.75; q=0.001), 
and VS-IFG (r(16)=0.50; q=0.048).  
Mediation analyses (Fig.3B) revealed that 1) the FC strength between VS-Insula 
mediated the association between ICD severity and right insula regional activation (F(2, 
17)=10.28, p=0.002); and, 2) connectivity between VS-IFG mediated the association 





Figure 3 (A) Right brain rendering including pairs of nodes (VS-STN, VS-IFG, VS-
Insula) that showed significant positive associations between the functional connectivity 
among them during the negative feedback condition and ICD severity (QUIP-RS). (B) 
Mediation analyses revealing that positive associations between ICD severity and 
regional activation of right insula and right IFG during negative feedback were 
mediated by the functional connectivity of these respective regions with the right VS. 
STN = subthalamic nucleus; VS = ventral striatum; IFG = inferior frontal gyrus.	
 
4. DISCUSION 
Based on previous evidence, we postulated that PD-ICD patients would exhibit 
differential neural dynamics involving the mesocorticolimbic dopaminergic circuit 
during the execution of a reward-related task. This was in fact the case, and even where 
behavioral performance was equivalent, PD-ICD patients exhibited differential patterns 
of activation and FC compared to PD-noICD patients and HC. Compared to PD-noICD 
patients, PD-ICD patients showed hyperactivation that was restricted to the right-
hemisphere cortical and subcortical regions associated with reward processing and 
inhibitory control. In fact, the higher the severity of ICD, the higher the regional 
activation of these areas, especially when patients were faced with penalties. Moreover, 
PD-ICD patients exhibited higher peaks in signal intensity during early processing of 
negative rewards in conflict detection areas, such as the insula; and reward processing 
regions, such as the right VS. A compelling finding was that functional coupling with 
right VS mediated the relation between ICD severity and the engagement of right-
lateralized inhibitory control regions (insula, IFG) during negative rewards in PD-ICD 
patients. These observations demonstrate that inhibitory control regions in PD-ICD 
patients are modulated by the right VS, which appears to orchestrate reward-processing 
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dynamics when patients face penalties requiring inhibitory control. A novel finding of 
this study was the involvement of the right STN in this process. However, unlike insula 
and IFG, STN activity was not mediated by functional coupling with VS. Importantly, 
although previous works investigated motor inhibition in PD patients with and without 
ICD, this was the first study to investigate the neural correlates of reward and inhibitory 
control processes during a decision-making IGT in PD-ICD patients and the first to 
show the involvement of the STN in cognitive inhibitory control. 
ICD in PD is a multidimensional concept engaging alterations in certain cognitive 
functions, such as reward processing, learning from reward and loss, inhibitory control, 
risk-taking and conflict processing4. In this regard, the IGT assesses patterns of 
decision-making under risk34, which requires the integration of processes conducted by 
different neural systems related to inhibitory control, memory and to the limbic 
system18. Accordingly, it has been previously reported that a disruption of ventral 
fronto-striatal circuits in PD-ICD patients might result in a reduced ability to resist an 
immediate reward, despite long-term consequences, termed ‘myopia for the future’35. 
Clinical studies examining IGT performance in PD patients with or without ICD have 
either reported impaired decision-making,20,24,27 absence of differences28,36 or even a 
conservative attitude in PD patients compared to HC37. Due to the aforementioned 
discrepancies, here we used an in-scanner modified IGT task and out-scanner classical 
IGT task, with both tasks showing lack of behavioral differences among the groups here 
examined in line with previous evidence28,36,38. Of interest, despite this equivalence in 
behavioral performance, important differences in functional regional activation were 
observed between groups and in terms of FC in the PD-ICD group. 
PD-ICD patients exhibited hyperactivation of bilateral MFG, left OFC and right SMA 
when compared to HC. These results complement previous fMRI studies in PD-ICD 
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patients, which have underscored the critical role of the mesocorticolimbic cortical 
system, encompassing insular cortex, PFC and OFC7,10. In addition, lateral PFC, MFG 
and SMA are part of the same fronto-striatal pathway that exhibits an activation pattern 
associated with interference inhibition, inhibitory control and action cancellation39,40. In 
this sense, ICD in PD patients is a multifaceted construct, including choice impulsivity 
and impairments in goal-directed behavior41, which have been shown to rely on 
different neural networks42,43. Compared to PD-noICD patients, PD-ICD patients 
showed stronger activation in right hemisphere subcortical areas (STN and VS) and in a 
cortical region strongly associated with inhibitory control: the IFG44. The involvement 
of the STN in impulsive behavior in PD has been widely investigated. Oscillatory 
activity recorded in the STN of PD patients treated with deep brain stimulation is 
modified during the execution of motor inhibition tasks45–47 and during inhibition of 
inappropriate or habitual prepotent responses48,49. fMRI studies have also revealed that 
during motor inhibition tasks there is hyperactivation of the right STN in control 
subjects, which is functionally connected to the right IFG and right pre-SMA through 
the hyperdirect pathway50. The IFG and STN are considered key nodes in the motor 
inhibition network; their activity is interrelated and also correlates with the extent of 
inhibition exercised51. Moreover, PD-ICD patients exhibit higher power in low 
frequency oscillations that is coherent with the oscillatory activity recorded in the 
prefrontal cortex52. On the other hand, the VS plays a central role in the 
mesocorticolimbic incentive network enabling the behavior-reinforcing effects of 
rewarding activities. Indeed, it has been extensively found that the VS, mostly in the 
right hemisphere, is implicated in the physiopathology of ICD in PD patients, and in 
keeping with these results, increased activation in the right VS could be related to 
increased dopamine release consistent with previous neuroimaging data5. Finally, right 
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IFG has been classically involved in inhibitory control along with lateral PFC and 
SMA44. The stronger engagement of all these regions in PD-ICD patients could be 
determined by the dopaminergic overstimulation of the mesolimbic areas that occurs in 
these patients, leading them toward aberrant reward evaluation. Our results also open 
the door for further research and therapeutic interventions, especially in the right STN 
and right VS, both areas where activation can be modulated by deep brain stimulation.  
Time-course analysis pointed towards higher early BOLD signal intensity during the 
processing of negative rewards in PD-ICD patients in bilateral insula and right VS. It is 
known that dopaminergic medications can influence cognitive processes in PD patients, 
and supporting evidence points towards impaired learning from negative feedback that 
in PD-ICD patients has been characterised by a VS critic model4,53,54. In the present 
study, PD-ICD group differences in processing negative rewards occurred at the neural 
level without showing a differential group effect on behavioural performance. By 
contrast, PD patients without this complication have been characterised by a dorsal 
actor model with higher learning rates from positive feedback54. Murine models have 
also endorsed this theory as nucleus accumbens D2 stimulation with dopamine agonists 
reduced ability to learn from negative feedback15. Our results showing earlier peaks 
when facing penalties in regions involved in conflict monitoring, such as the right 
insula55, and in reward processing, such as the right VS12, might underlie a differential 
processing of negative rewards in PD-ICD patients during initial prediction errors and 
evaluation of rewards that precedes the normal posterior course of activation. So, this 
initial activation peak may be necessary to adjust PD-ICD neural responses to process 
subsequent penalties in a reward-processing context. Future neuroimaging studies using 
tasks requiring more transient functional processing of negative rewards in PD-ICD 
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patients may lead to the identification of concomitant group differences at the neural 
and behavioral levels.  
Regarding FC, we observed that right VS functional coupling mediates the relation 
between ICD severity and the engagement of regions involved in conflict evaluation 
processes (insula) and inhibitory control (IFG) during negative rewards in PD-ICD 
patients56. Thus, in this context the right VS appears to be a critical hub. Previous 
evidence has revealed altered striato-cortical connectivity in PD-ICD patients, showing 
controversial results such as, on the one hand, reduced connectivity between dorsal 
striatum and temporal and cingulate cortices57, and, on the other hand, stronger 
connectivity between right VS and fronto-temporal cortical areas12. Our results suggest 
that the coupling of the right VS with these two regions may serve as a bridge for 
communication between the reward system and cognitive control areas resulting in 
higher activation of those inhibitory control regions.  
It is remarkable that although the connectivity between STN and VS was positively 
correlated with ICD severity, the VS did not mediate the association between STN 
recruitment and ICD severity. Although it is hard to make further sense of a null effect, 
the STN seems to be specifically engaged in late response inhibitory processes as 
reflected by studies showing a correlation between STN activation and longer stop 
signal delays58. As our time-course analysis revealed that only PD-ICD patients showed 
different signal intensity in the initial periods after being presented with negative 
feedback, it could be that STN and IFG involvement would be greater in later phases. In 
fact, the STN-IFG pathway is more activated in the global inhibition59 and late 
inhibition phases as has been observed after right STN lesions in PD patients60. Future 
neuroimaging research including both response and cognitive inhibitory tasks with PD-
ICD patients could further disentangle these possibilities.  
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These findings should be considered in the context of several limitations. First, all 
patients in this study were on their regular medication; this was intentional as ICD is a 
complication to which dopaminergic medication is the main contributor. However, we 
ensured that both groups of patients were receiving similar daily doses of 
antiparkinsonian medication to avoid any pharmacological confound. Second, as our 
sample was heterogeneous because of mixed ICD types, we decided to choose a global 
reward (an economic reward) and interpreted the results on this basis. Also for this 
reason, we tried not to choose PD-ICD patients with problems in only one ICD modality 
to avoid introducing a bias and because based on previous evidence it is reasonable to 
assume that the neural substrates in PD-ICD patients are similar for all modalities. 
The theoretical and neurological framework presented here suggests that PD-ICD 
patients have enhanced activation in regions involved in the encoding of rewards and 
inhibitory control during disadvantageous outcomes, compared with PD-noICD and 
healthy controls. PD-ICD patients show hyperactivation during stimuli evaluation, 
conflict detection and monitoring areas during the early processing of negative rewards. 
In addition, in these patients, right VS appears to be a critical region that orchestrates 
hyperactivation in right-lateralized inhibitory-control frontal regions when facing 
penalties. Interestingly, the right STN is also a relevant area for cognitive inhibitory 
control although its activation is not modulated by the right VS. Importantly, although 
we found no group differences in behavioral performance, the neural dynamics in PD-
ICD patients were different to those in PD-noICD patients and HCs, providing new 
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Classical and Modified Iowa Gambling Talks (IGT) 
The classical IGT is a computerized measure that was originally developed to evaluate defective 
decision-making observed in patients with damage to the ventromedial prefrontal cortex 
(vmPFC)1. These patients often engaged in risky or impulsive behavior in their daily lives and 
seemed unable to learn from the consequences of their poor judgment, but performed normally 
on neuropsychological measures of executive function1,2. The IGT simulates a card game in 
which the player tries to win ‘money’ by choosing cards from four decks. Each deck contains 
cards that award money (positive rewards/feedback) but may also take money away (negative 
rewards/feedback). Two decks (A&B) are disadvantageous decks that provide large rewards but 
even larger punishments resulting in a net loss over time. Two other decks (C&D) are 
advantageous decks that provide small rewards but even smaller punishments resulting in a net 
gain over time. Examinees are told in advance that they must accrue as much ‘money’ as 
possible. The primary dependent variable is the number of advantageous minus disadvantageous 
selections in each block of 20 trials [(C + D) – (A + B)]. Successful performance in the IGT 
requires intact decision-making, reversal learning, impulse control, mental flexibility, and 
reward/punishment sensitivity3–5. Over time, the players ideally learn that choosing from the 
two advantageous decks will maximize their winnings. However, players with damage to the 
vmPFC typically persist in choosing from the disadvantageous decks which yield higher 
rewards even as their losses mount1,2. Bechara and colleagues referred to this neglect of future 
consequences and single-minded focus on desirable present outcomes as ‘myopia for the 
future’3,6. In addition to the original clinical population of vmPFC patients, the IGT has also 
demonstrated sensitivity to poor decision-making skills in other patient groups with impulsive 
behaviors, including substance abuse patients and pathological gamblers. These non-lesion 
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groups are typically not as severely impaired and eventually develop some preference for the 
advantageous decks7,8. 
The modified IGT used in the scanner was a simplified version of the classical IGT designed to 
minimize motor difficulties experienced by PD patients during scanning and to assure that they 
could understand the IGT contingencies. Instead of the original version (with decks A, B, C and 
D), we used a version with only two decks (A and B). One of the decks was disadvantageous, 
providing larger gains but larger losses resulting in a net loss over time. The other deck was 
advantageous, providing smaller gains but smaller losses resulting in a net gain over time. These 
deck contingencies were kept consistent across conditions (i.e., positive, negative and mixed), 
regardless of the feedback specifically provided in each of these conditions. Similar to the 
classical IGT, participants were told in advance that they must accrue as much ‘money’ as 
possible. The primary dependent variable was the number of advantageous selections minus 
disadvantageous selections. The subject chose a card from either of the two decks, then a 
message was displayed on the screen indicating the amount of money the subject had won or 
lost. The task was divided into 3 conditions, always presented in the same sequential order: (1) 
only positive feedback was presented, so the participants could get familiarized with the decks 
providing lower and higher gains (positive); (2) negative feedback was presented, so 
participants could get familiarized with the decks providing higher and lower losses (negative); 
and, (3) positive and negative feedback was provided, so participants could either win or lose 
money based on the contingencies learned in sections 1 and 2.  Participants performed this 
modified version of the IGT across three functional runs. Within each of these functional runs, 
participants performed two blocks, each including the three sequential sections (6 in total). 
Blocks presented within the same functional run differed from each other in regard to the 
advantageous/disadvantageous rules applied, and participants were instructed to ignore previous 
contingencies when moving from one block to the next. Between blocks participants performed 
a control task where they encountered two decks (A and B) with amounts displayed on top of 
the decks and just needed to choose the deck displaying the higher number. During this control 
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task the amounts that appeared in decks A and B were fully randomized and participants only 
needed to choose either deck based on the currently displayed amounts rather than on 
contingencies associated with the decks.  
Statistical analyses of clinical data 
SPSS v16.0 was used to perform statistical analyses on the demographic variables and 
the IGT performance. The distributions of demographic variables were tested for 
normality using the Shapiro-Wilk test. Sociodemographic differences between groups 
were tested with the Analysis of Variance (ANOVA) or Kruskal-Wallis test for 3-group 
comparisons and 2-tailed t-test or U-Mann Whitney for 2-group comparisons, 
respectively. IGT performance was analyzed in the conventional way by dividing the 
task into five blocks of 20 consecutive card selections. An ANOVA with repeated 
measures was performed using Group as between factor, Block as within factor and the 
Net score [(advantageous decks)-(disadvantageous decks)] as the dependent measure. 
For each statistic test, a two-tailed probability value of <0.05 was regarded as 
significant. 
MRI data acquisition 
Data were obtained at the Basque Center on Cognition, Brain and Language (BCBL) 3T 
Siemens Magnetom TIM Trio MRI scanner (Siemens Medical Solutions, Erlangen, Germany) 
using a 32-channel head coil. PD patients were under the effects of their usual dopaminergic 
medication during MRI scanning. Ear plugs and snugly-fitting headphones (MR Confon, 
Magdeburg, Germany) were used to dampen background scanner noise and to enable 
communication with experimenters while in the scanner. To limit head movement, the area 
between participants’ heads and the coil was padded with foam and participants were asked to 
remain as still as possible. 
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Functional images were acquired in three separate runs using a gradient-echo echo-
planar pulse sequence with the following acquisition parameters: TR = 2000 ms, time 
echo (TE) = 28 ms, 33 contiguous 3 mm3 axial slices, 10% inter-slice gap, flip angle 
(FA) = 90º, field of view (FoV) = 192 x 192 mm. 320 volumes were collected per 
functional run. Prior to each scan, four volumes were discarded to allow for T1-
Equilibration effects. Structural T1-weighted images were acquired with a MPRAGE 
sequence with TR = 2530 ms, TE = 2.97 ms, inversion time = 1100 ms, FA = 7°, FoV = 
256x256 mm, 176 slices and voxel size = 1 mm3. 
MRI data analyses 
SPM8 (Welcome Department of Cognitive Neurology, London) was used to conduct standard 
preprocessing routines and analyses. Images were corrected for differences in timing of slice 
acquisition and were realigned to the first volume by means of rigid-body transformation. Then, 
functional images were spatially smoothed using a 4-mm full width at half-maximum (FWHM) 
isotropic Gaussian kernel. Next, motion parameters obtained from realignment were used to 
inform a volume repair procedure (ArtRepair; Stanford Psychiatric Neuroimaging Laboratory) 
that identified bad volumes on the basis of within-scan movement and signal fluctuations, and 
then corrected bad signal values via interpolation. A volume-by-volume correction with a 0.5 
mm threshold was applied, which did not correct more than 20% of the total volumes in any 
participant. Six additional subjects not included in the final sample described in the participants 
section above were excluded due to excessive motion with either more than 20% to-be-repaired 
functional volumes or drifts over 3 mm in any of the functional runs. After volume repair, 
structural and functional volumes were corregistered and spatially normalized to T1 and echo-
planar imaging templates, respectively. The normalization algorithm used a 12-parameter affine 
transformation together with a non-linear transformation involving cosine basis functions. 
During normalization, the volumes were sampled to 3-mm cubic voxels. Templates were based 
on the MNI305 stereotaxic space. Then, functional volumes were spatially smoothed with a 7-
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mm FWHM isotropic Gaussian kernel. Finally, a 128 sec high-pass filter was used to eliminate 
contamination from slow drift of signals. 
Statistical analyses were performed on individual participants’ data using the general linear 
model (GLM). The fMRI time series data were modeled by a series of events convolved with a 
canonical hemodynamic response function. Four fMRI task experimental conditions were 
analyzed separately as epochs from the onset of the presentation of the first stimulus within each 
section (positive feedback, negative feedback, mixed feedback) and control task. The resulting 
functions were used as covariates in a GLM, along with the motion parameters for translation 
(i.e., x, y, z) and rotation (i.e., yaw, pitch, roll) as covariates of non-interest. The model was 
created to examine the neural changes restricted to the three task sections and the control task 
periods and was used in whole-brain contrast, regions-of-interest (ROIs), time course and 
functional connectivity (FC) analyses.  
The least-squares parameter estimates of the height of the best-fitting canonical HRF for each 
condition were used in pairwise contrasts. Contrast images, computed on a participant-by-
participant basis were submitted to group analysis. At the group level, the whole-brain contrasts 
between the three main conditions and the control condition were computed by performing one-
sample t-tests on these images, treating participants as a random effect. The standard statistical 
threshold for whole-brain map involving all participants and contrasting all the experimental 
conditions versus the control task (i.e., All Conditions > Control) was a voxel-wise corrected 
false discovery rate (FDR) set at q < 0.01. Brain coordinates in this manuscript are reported in 
Montreal Neurological Institute (MNI) atlas space9. 
ROI analyses were performed with the MARSBAR toolbox for use with SPM810. ROIs 
consisted of significantly active voxels identified from the All Conditions > Control whole-
brain contrast (q < 0.01, voxel-wise FDR corrected) across all participants within specific 
MARSBAR anatomical ROIs. A set of ROIs (the center of mass and the volume in cubic mm 
are indicated between parentheses) were built, including: left middle frontal gyrus (MFG) (-39, -
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33, 32; 17760 mm3), left orbitofrontal (OFC) (-38, 52, -7; 3024 mm3), left insula (-35, 19, -2; 
1256 mm3), right MFG (38, 34, 32; 30208 mm3), right supplementary motor area (SMA) (9, 20, 
59; 2360 mm3), right inferior frontal gyrus (IFG) (46, 25, 9; 11864 mm3), right insula (38, 20, -
3; 2824 mm3), right subthalamic nucleus (STN) (15, -13, -4; 162 mm3) and right ventral 
striatum (VS) (21, 10, -7; 3944 mm3). One-way analysis of variance (ANOVA) followed by 
Scheffé post-hoc analyses were used to compare results among groups in each ROI. 
We also performed time-course analyses for the fMRI trials. Blood Oxygen Level Dependent 
(BOLD) activity time series, averaged across all voxels in each ROI, were extracted for each 
functional run. Mean time courses for each trial were then constructed by averaging together 
appropriate trial time courses per condition, which were defined as 16 sec windows of activity 
after trial onset. In detail, these 16 seconds were divided into two periods: an initial period from 
0 to 8 seconds and a final period from 8 to 16 seconds. These condition-averaged time courses 
were then averaged across functional sessions and across participants. For each ROI, we 
performed a mixed-model ANOVA on the BOLD signal intensity with the factors Group (PD-
ICD, PD-noICD, HC), Condition (positive feedback, negative feedback, mixed feedback), and 
Time (initial period, final period).  
To examine associations between regional hyperactivation and ICD severity in PD-ICD 
patients, we conducted one-tailed Pearson correlation analyses between the percentage signal 
change observed in the previously mentioned regions of interest and the QUIP-RS scores, 
correcting for multiple comparisons (q < 0.05, FDR).  
We assessed FC via the beta series correlation method11 implemented in SPM8 with custom 
Matlab scripts. The canonical HRF in SPM was fit to each occurrence of each condition and the 
resulting parameter estimates (beta values) were sorted according to the study conditions of 
interest to produce a condition-specific beta series for each voxel. Pairwise FC analyses were 
conducted for the negative feedback condition calculating the beta-series correlation values for 
each pair of right-lateralized ROIs that showed significant positive associations with ICD 
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severity in the PD-ICD group (i.e., STN, VS, insula, IFG, SMA, and MFG). Since the 
correlation coefficient is inherently restricted to range from −1 to +1, an arc-hyperbolic tangent 
transform12 was applied to these beta-series correlation values (r values) to make its null 
hypothesis sampling distribution approach that of the normal distribution. To examine 
associations between FC among these six ROIs and ICD severity, we conducted two-tailed 
Pearson correlation analyses between Fisher z-score transformed beta-series correlation values 
and the QUIP-RS scores, correcting for multiple comparisons (q < 0.05, FDR).  
Finally, mediation analyses were conducted to examine whether in PD-ICD patients pairwise 
FC between nodes (i.e., right-lateralized STN-VS, VS-IFG and VS-Insula) during the negative 
feedback condition mediates the relation between ICD severity and regional functional 
activation of areas critically involved in conflict detection and inhibitory control processes. To 
this end, we followed the four steps described by Baron and Kenny to establish mediation13. A 
significant mediator was indicated when the relationship between the ICD severity (QUIP-RS) 









Supplementary Figure 1. IGT performance over time in PD-ICD, PD-noICD and HC groups. 
The result is the difference between the percentage of advantageous choices minus the 




As in the IGT task performed during the neuropsychological investigations, no significant 
differences were found between groups. The ANOVA on the net scores revealed no significant 
main effects of Group (F (2, 50) = 0.19; p = 0.82, ηp2 = 0.08) nor Group by Condition by Run 
interaction (F (4, 50) = 0.78; p = 0.54, ηp2 = 0.03) or other interaction between factors.   
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MoCA	 27	(2.2)	 27.3	(3)	 28	(1.7)	 0.444
a
	
Digit	span	forward	 6	[5-6.7]	 6	[4.6-7.2]	 7	[6.2-7.1]	 0.134
b
	
Digit	span	backwards	 4	[3.9-5.6]	 4	[3.1-5.7]	 5	[4.2-6.5]	 0.117b	
TMT-A	(s)	 46.35	[23.4-54.1]	 39.8	[25.5-46.2]	 34.5	[22.2-45.3]	 0.418b	
TMT-B	(s)	 88.5	[63.3-118.7]	 82.2	[61.4-95.8]	 71.2	[59-95.4]	 0.493b	
Stroop	words	 96.1	(18.2)	 93	(26.3)	 106.6	(21.5)	 0.180a	
Stroop	colors	 60.9	(14.8)	 59.2	(19.4)	 69.2	(14.9)	 0.174a	
Stroop	words-colors	 33.4	(11.8)	 34	(13.1)	 41	(12)	 0.135a	
Phonemic	fluency	(initial	letter)	 16.1	(5.5)	 14.4	(5.4)	 18.2	(5.7)	 0.112a	
LNS	 11.1	[8.5-11.3]	 10	[8.2-11.1]	 11.6	[11-2-13.7]	 0.333b	
RAVLT	total	recall	 46.3	(7.8)	 47.7	(16.1)	 50.7	(9.8)	 0.228a	
RAVLT	delayed	recall	 9.1	(2.9)	 8.6	(4.7)	 9.7	(3.6)	 0.103a	
RAVLT	recognition	 14	[11.8-15.2]	 12	[7-14.3]	 14.2	[13.5-15.6]	 0.378b	
Semantic	fluency	(animals)	 21.5	(5.6)	 20	(7.6)	 23.1	(4.8)	 0.328a	
Boston	naming	test	 12	[9.8-13.2]	 13	[10.7-14.5]	 13.5	[12.4-15.8]	 0.416b	
VOSP	Object	decision	
	
16.8	(2.1)	 16	(4.5)	 17.5	(2.1)	 0.517a	











Supplementary Table 2 Characteristics of ICD in PD patients. 
 
	




ICD Other ICDs DA 
PD-ICD 1 M 64 BE Hobbysm Pramipexole 




M = male; F = female; BE = binge eating; HS = hypersexuality; CS = compulsive shopping; PG = 




PD-ICD 3 M 59 BE - Pramipexole 
PD-ICD 4 F 64 CS Hobbysm Pramipexole 
PD-ICD 5 M 65 BE CS, hobbysm Ropinirole 
PD-ICD 6 M 61 CS Hobbysm Rotigotine 
PD-ICD 7 M 48 HS - - 
PD-ICD 8 M 68 HS BE Pramipexole 
PD-ICD 9 M 57 PG BE Pramipexole 
PD-ICD 10 M 44 BE Hobbysm Rotigotine 
PD-ICD 11 M 61 BE - Pramipexole 
PD-ICD 12 M 58 BE Hobbysm Apomorphine sc  
PD-ICD 13 M 71 HS CS, BE Rotigotine 
PD-ICD 14 M 75 HS - Rotigotine 
PD-ICD 15 M 68 HS, CS Hobbysm, Punding Ropinirole 
PD-ICD 16 M 65 HS BE Pramipexole 
PD-ICD 17 M 60 CS HS, BE, Punding Rotigotine 
PD-ICD 18 F 69 BE - Rotigotine 
